abstract |
The present invention relates to inhibitors of catechol O-methyltransferase (COMT) and to 4-pyridinone compounds useful in the treatment and prevention of neurological and psychiatric disorders and diseases involving COMT enzymes. The present invention also relates to pharmaceutical compositions comprising such compounds and the use of such compounds and compositions in the prophylaxis or treatment of diseases associated with COMT. |